Cogent Biosciences
COGT
COGT
135 hedge funds and large institutions have $1.05B invested in Cogent Biosciences in 2023 Q2 according to their latest regulatory filings, with 17 funds opening new positions, 59 increasing their positions, 39 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
1% less funds holding
Funds holding: 136 → 135 (-1)
6% less first-time investments, than exits
New positions opened: 17 | Existing positions closed: 18
21.92% less ownership
Funds ownership: 107.6% → 85.68% (-22%)
Holders
135
Holding in Top 10
7
Calls
$234K
Puts
$13K
Top Buyers
| 1 | +$29M | |
| 2 | +$24.3M | |
| 3 | +$23.7M | |
| 4 |
KCM
Kynam Capital Management
Princeton,
New Jersey
|
+$14.4M |
| 5 |
SVCM
Saturn V Capital Management
Austin,
Texas
|
+$13.5M |
Top Sellers
| 1 | -$13.7M | |
| 2 | -$7.79M | |
| 3 | -$4.08M | |
| 4 |
MFS
Mirabella Financial Services
London,
United Kingdom
|
-$3.99M |
| 5 |
State Street
Boston,
Massachusetts
|
-$3.55M |